Title |
Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
|
---|---|
Published in |
PLOS ONE, January 2010
|
DOI | 10.1371/journal.pone.0008816 |
Pubmed ID | |
Authors |
Sandhya Vasan, Sarah J. Schlesinger, Zhiwei Chen, Arlene Hurley, Angela Lombardo, Soe Than, Phumla Adesanya, Catherine Bunce, Mark Boaz, Rosanne Boyle, Eddy Sayeed, Lorna Clark, Daniel Dugin, Mar Boente-Carrera, Claudia Schmidt, Qing Fang, Ba Lei, Yaoxing Huang, Gerasimos J. Zaharatos, David F. Gardiner, Marina Caskey, Laura Seamons, Martin Ho, Len Dally, Carol Smith, Josephine Cox, Dilbinder Gill, Jill Gilmour, Michael C. Keefer, Patricia Fast, David D. Ho |
Mendeley readers
The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Canada | 1 | 3% |
South Africa | 1 | 3% |
Unknown | 32 | 91% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 17% |
Student > Master | 4 | 11% |
Student > Bachelor | 4 | 11% |
Librarian | 2 | 6% |
Other | 2 | 6% |
Other | 10 | 29% |
Unknown | 7 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 23% |
Agricultural and Biological Sciences | 7 | 20% |
Immunology and Microbiology | 3 | 9% |
Biochemistry, Genetics and Molecular Biology | 2 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 6% |
Other | 5 | 14% |
Unknown | 8 | 23% |